找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Esophageal Cancer; Prevention, Diagnosi Nabil F. Saba,Bassel F. El-Rayes Book 2020Latest edition Springer Nature Switzerland AG 2020 Stagin

[復(fù)制鏈接]
樓主: TRACT
21#
發(fā)表于 2025-3-25 07:14:26 | 只看該作者
Radiologic Assessment of Esophageal Cancer, different conventional anatomic modalities such as esophagograms, endoscopic ultrasound, CT, and MRI are explained. In addition, the role of PET/CT, a functional and anatomic modality, is illustrated. In this chapter, the specific role of each modality is explained for each of the pillars of stagin
22#
發(fā)表于 2025-3-25 08:38:12 | 只看該作者
23#
發(fā)表于 2025-3-25 12:41:10 | 只看該作者
24#
發(fā)表于 2025-3-25 19:44:40 | 只看該作者
25#
發(fā)表于 2025-3-25 21:34:56 | 只看該作者
26#
發(fā)表于 2025-3-26 00:25:14 | 只看該作者
27#
發(fā)表于 2025-3-26 05:36:41 | 只看該作者
28#
發(fā)表于 2025-3-26 11:36:43 | 只看該作者
Systemic Treatment for Metastatic or Recurrent Disease,ismal, where the malignancy is refractory to conventional cytotoxic chemotherapy and associated with poor prognosis. While therapeutic advances over the past several years have resulted in improved patient outcomes, the observed benefits have been modest, highlighting the need for the identification
29#
發(fā)表于 2025-3-26 14:18:45 | 只看該作者
Immunotherapy in Esophageal Cancer,es has been shown to improve outcomes in a number of solid tumors, leading to their routine use in clinical practice. Early phase evaluation of immune checkpoint inhibitors demonstrated encouraging results in esophageal cancer, and studies in the chemorefractory setting have confirmed the activity o
30#
發(fā)表于 2025-3-26 20:32:06 | 只看該作者
Palliative Approaches in Esophageal Cancer,ophageal cancer remains a devastating disease in the world. Early diagnosis is difficult, since dysphagia, the common presentation symptom, occurs in late stage of the disease. When diagnosed, many patients miss the opportunity for surgical therapy. Also, patients with esophageal cancer are usually
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 22:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
康平县| 沛县| 喀喇| 齐齐哈尔市| 斗六市| 铁岭市| 武宁县| 伊川县| 泽库县| 武夷山市| 锦州市| 夹江县| 天等县| 香河县| 桂林市| 盐山县| 彭泽县| 鹤山市| 昌黎县| 安溪县| 刚察县| 青冈县| 高唐县| 禄劝| 太湖县| 开远市| 永丰县| 奉节县| 乌鲁木齐县| 神池县| 岢岚县| 柘城县| 苍溪县| 噶尔县| 枣强县| 武山县| 满洲里市| 庆云县| 横山县| 抚宁县| 藁城市|